Reduction in Cerebral Perfusion after Heroin Administration: A Resting State Arterial Spin Labeling Study

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Denier, Niklaus ^a   Gerber, Hana ^a,b   Vogel, Marc ^a   Klarhöfer, Markus ^a   Riecher Rossler, Anita ^a   Wiesbeck, Gerhard A ^a   Lang, Undine E ^a   Borgwardt, Stefan ^a   Walter, Marc ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; SODIUM CHLORIDE;

ADULT; ANTERIOR CINGULATE; ARTICLE; AUTOREGULATION; BRAIN PERFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; EMOTIONALITY; FEMALE; FLOW SENSITIVE ALTERNATING INVERSION RECOVERY SPIN LABELING; GRADIENT SPIN ECHO; HEROIN DEPENDENCE; HUMAN; INSULA; INTERMETHOD COMPARISON; LEFT HEMISPHERE; MALE; MEDIAL PREFRONTAL CORTEX; NUCLEAR MAGNETIC RESONANCE IMAGING; PHARMACOLOGICAL MAGNETIC RESONANCE IMAGING; PREFRONTAL CORTEX; PULSED ARTERIAL SPIN LABELING; RANDOMIZED CONTROLLED TRIAL; REST; SEX DIFFERENCE; SPIN LABELING;

ADULT; CEREBRAL ARTERIES; CROSS-OVER STUDIES; FEMALE; GYRUS CINGULI; HEROIN; HEROIN DEPENDENCE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NARCOTICS; PREFRONTAL CORTEX; REGIONAL BLOOD FLOW; SINGLE-BLIND METHOD;

EID: 84883774075     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071461     Document Type: Article

References (53)

1. Koob GF, Le Moal M, (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278: 52-58.
2. Walter M, Wiesbeck G, Bloch N, Aeschbach S, Olbrich H, et al. (2008) Psychobiological responses to drug cues before and after methadone intake in heroin-dependent patients: a pilot study. Eur Neuropsychopharmacol 18: 390-393.
3. Walter M, Wiesbeck GA, Degen B, Albrich J, Oppel M, et al. (2011) Heroin reduces startle and cortisol response in opioid-maintained heroin-dependent patients. Addict Biol 16: 145-151.
4. Uchtenhagen A, (2010) Heroin-assisted treatment in Switzerland: a case study in policy change. Addiction 105: 29-37.
5. Rook EJ, Huitema AD, van den Brink W, van Ree JM, Beijnen JH, (2006) Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature. Curr Clin Pharmacol 1: 109-118.
6. Inturrisi CE, Schultz M, Shin S, Umans JG, Angel L, et al. (1983) Evidence from opiate binding studies that heroin acts through its metabolites. Life Sci 33 (Suppl 1) (): 773-776.
7. Boix F, Andersen JM, Morland J, (2011) Pharmacokinetic modeling of subcutaneous heroin and its metabolites in blood and brain of mice. Addict Biol.
8. Tschacher W, Haemmig R, Jacobshagen N, (2003) Time series modeling of heroin and morphine drug action. Psychopharmacology (Berl) 165: 188-193.
9. Raehal KM, Bohn LM, (2005) Mu opioid receptor regulation and opiate responsiveness. AAPS J 7: E587-591.
10. Walker DJ, Zacny JP, (1999) Subjective, psychomotor, and physiological effects of cumulative doses of opioid mu agonists in healthy volunteers. J Pharmacol Exp Ther 289: 1454-1464.
11. Walker DJ, Zacny JP, Galva KE, Lichtor JL, (2001) Subjective, psychomotor, and physiological effects of cumulative doses of mixed-action opioids in healthy volunteers. Psychopharmacology (Berl) 155: 362-371.
12. Earleywine M (2005) Mind-altering drugs: the science of subjective experience. Oxford; New York: Oxford University Press. x, 402 p. p.
13. Kosel M, Noss RS, Hammig R, Wielepp P, Bundeli P, et al. (2008) Cerebral blood flow effects of acute intravenous heroin administration. Eur Neuropsychopharmacol 18: 278-285.
14. Seecof R, Tennant FS Jr, (1986) Subjective perceptions to the intravenous "rush" of heroin and cocaine in opioid addicts. Am J Drug Alcohol Abuse 12: 79-87.
15. MacIntosh BJ, Pattinson KT, Gallichan D, Ahmad I, Miller KL, et al. (2008) Measuring the effects of remifentanil on cerebral blood flow and arterial arrival time using 3D GRASE MRI with pulsed arterial spin labelling. J Cereb Blood Flow Metab 28: 1514-1522.
16. van Hell HH, Bossong MG, Jager G, Kahn RS, Ramsey NF, (2011) Methods of the pharmacological imaging of the cannabinoid system (PhICS) study: towards understanding the role of the brain endocannabinoid system in human cognition. Int J Methods Psychiatr Res 20: 10-27.
17. Carhart-Harris RL, Erritzoe D, Williams T, Stone JM, Reed LJ, et al. (2012) Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc Natl Acad Sci U S A 109: 2138-2143.
18. Schouw ML, Gevers S, Caan MW, Majoie CB, Booij J, et al. (2011) Mapping serotonergic dysfunction in MDMA (ecstasy) users using pharmacological MRI. Eur Neuropsychopharmacol.
19. Luo F, Schmidt KF, Fox GB, Ferris CF, (2009) Differential responses in CBF and CBV to cocaine as measured by fMRI: implications for pharmacological MRI signals derived oxygen metabolism assessment. J Psychiatr Res 43: 1018-1024.
20. Bhattacharyya S, Crippa JA, Allen P, Martin-Santos R, Borgwardt S, et al. (2012) Induction of psychosis by Delta9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing. Arch Gen Psychiatry 69: 27-36.
21. Winton-Brown TT, Allen P, Bhattacharyya S, Borgwardt SJ, Fusar-Poli P, et al. (2011) Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study. Neuropsychopharmacology 36: 1340-1348.
22. Bhattacharyya S, Fusar-Poli P, Borgwardt S, Martin-Santos R, Nosarti C, et al. (2009) Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis. Arch Gen Psychiatry 66: 442-451.
23. Fusar-Poli P, Crippa JA, Bhattacharyya S, Borgwardt SJ, Allen P, et al. (2009) Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch Gen Psychiatry 66: 95-105.
24. Borgwardt SJ, Allen P, Bhattacharyya S, Fusar-Poli P, Crippa JA, et al. (2008) Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition. Biol Psychiatry 64: 966-973.
25. Denier N, Walter M, Bendfeldt K, Lang U, Borgwardt S, (2012) Resting state abnormalities in psychosis compared to acute cannabinoids and opioids challenges: A systematic review of functional imaging studies. Curr Pharm Des.
26. Wang DJ, Chen Y, Fernandez-Seara MA, Detre JA, (2011) Potentials and challenges for arterial spin labeling in pharmacological magnetic resonance imaging. J Pharmacol Exp Ther 337: 359-366.
27. Tiffany ST, (1999) Cognitive concepts of craving. Alcohol Res Health 23: 215-224.
28. Gunther M, Oshio K, Feinberg DA, (2005) Single-shot 3D imaging techniques improve arterial spin labeling perfusion measurements. Magn Reson Med 54: 491-498.
29. Kim SG, (1995) Quantification of relative cerebral blood flow change by flow-sensitive alternating inversion recovery (FAIR) technique: application to functional mapping. Magn Reson Med 34: 293-301.
30. Amann M, Achtnichts L, Hirsch JG, Naegelin Y, Gregori J, et al. (2012) 3D GRASE arterial spin labelling reveals an inverse correlation of cortical perfusion with the white matter lesion volume in MS. Mult Scler.
31. Petersson KM, Nichols TE, Poline JB, Holmes AP, (1999) Statistical limitations in functional neuroimaging. II. Signal detection and statistical inference. Philos Trans R Soc Lond B Biol Sci 354: 1261-1281.
32. Allman JM, Hakeem A, Erwin JM, Nimchinsky E, Hof P, (2001) The anterior cingulate cortex. The evolution of an interface between emotion and cognition. Ann N Y Acad Sci 935: 107-117.
33. Nagai M, Kishi K, Kato S, (2007) Insular cortex and neuropsychiatric disorders: a review of recent literature. Eur Psychiatry 22: 387-394.
34. Northoff G, Heinzel A, de Greck M, Bermpohl F, Dobrowolny H, et al. (2006) Self-referential processing in our brain-a meta-analysis of imaging studies on the self. Neuroimage 31: 440-457.
35. Langleben DD, Ruparel K, Elman I, Busch-Winokur S, Pratiwadi R, et al. (2008) Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues. Am J Psychiatry 165: 390-394.
36. Daglish MR, Weinstein A, Malizia AL, Wilson S, Melichar JK, et al. (2003) Functional connectivity analysis of the neural circuits of opiate craving: "more" rather than "different"? Neuroimage 20: 1964-1970.
37. Guyer S, Kosel M, Altrichter S, El-Koussy M, Haemmig R, et al. (2007) Pattern of regional cerebral blood-flow changes induced by acute heroin administration-a perfusion MRI study. J Neuroradiol 34: 322-329.
38. Detre JA, Wang J, Wang Z, Rao H, (2009) Arterial spin-labeled perfusion MRI in basic and clinical neuroscience. Curr Opin Neurol 22: 348-355.
39. Ye FQ, Berman KF, Ellmore T, Esposito G, van Horn JD, et al. (2000) H(2)(15)O PET validation of steady-state arterial spin tagging cerebral blood flow measurements in humans. Magn Reson Med 44: 450-456.
40. Zelaya FO, Zois E, Muller-Pollard C, Lythgoe DJ, Lee S, et al. (2012) The response to rapid infusion of fentanyl in the human brain measured using pulsed arterial spin labelling. MAGMA 25: 163-175.
41. Kofke WA, Blissitt PA, Rao H, Wang J, Addya K, et al. (2007) Remifentanil-induced cerebral blood flow effects in normal humans: dose and ApoE genotype. Anesth Analg 105: 167-175.
42. London ED, Broussolle EP, Links JM, Wong DF, Cascella NG, et al. (1990) Morphine-induced metabolic changes in human brain. Studies with positron emission tomography and [fluorine 18]fluorodeoxyglucose. Arch Gen Psychiatry 47: 73-81.
43. Pezawas L, Fischer G, Podreka I, Schindler S, Brucke T, et al. (2002) Opioid addiction changes cerebral blood flow symmetry. Neuropsychobiology 45: 67-73.
44. Gerber H, Borgwardt SJ, Schmid O, Gerhard U, Joechle W, et al. (2012) The impact of diacetylmorphine on hypothalamic-pituitary-adrenal axis activity and heroin craving in heroin dependence. Eur Addict Res 18: 116-123.
45. Yuan Y, Zhu Z, Shi J, Zou Z, Yuan F, et al. (2009) Gray matter density negatively correlates with duration of heroin use in young lifetime heroin-dependent individuals. Brain Cogn 71: 223-228.
46. Liu H, Hao Y, Kaneko Y, Ouyang X, Zhang Y, et al. (2009) Frontal and cingulate gray matter volume reduction in heroin dependence: optimized voxel-based morphometry. Psychiatry Clin Neurosci 63: 563-568.
47. Cechetti F, Pagnussat AS, Worm PV, Elsner VR, Ben J, et al. (2012) Chronic brain hypoperfusion causes early glial activation and neuronal death, and subsequent long-term memory impairment. Brain Res Bull 87: 109-116.
48. Otori T, Katsumata T, Muramatsu H, Kashiwagi F, Katayama Y, et al. (2003) Long-term measurement of cerebral blood flow and metabolism in a rat chronic hypoperfusion model. Clin Exp Pharmacol Physiol 30: 266-272.
49. Blum J, Gerber H, Gerhard U, Schmid O, Petitjean S, et al. (2013) Acute effects of heroin on emotions in heroin-dependent patients. American Journal on Addictions in press.
50. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, et al. (2001) A default mode of brain function. Proc Natl Acad Sci U S A 98: 676-682.
51. Gusnard DA, Akbudak E, Shulman GL, Raichle ME, (2001) Medial prefrontal cortex and self-referential mental activity: relation to a default mode of brain function. Proc Natl Acad Sci U S A 98: 4259-4264.
52. Raichle ME, Snyder AZ, (2007) A default mode of brain function: a brief history of an evolving idea. Neuroimage 37: 1083-1090; discussion 1097-1089.
53. Buckner RL, Andrews-Hanna JR, Schacter DL, (2008) The brain's default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci 1124: 1-38.